Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
|2||Not yet recruiting||
Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
|3||Active, not recruiting||
PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
† Study has passed its completion date and status has not been verified in more than two years.